Distribution of Body Fat and Its Influence on Esophageal Inflammation and Dysplasia in Patients With Barrett's Esophagus

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 7, 2012, Pages 728-734

  Nelsen, Eric M ^a   Kirihara, Yujiro ^a   Takahashi, Naoki ^a   Shi, Qian ^a   Lewis, Jason T ^a   Namasivayam, Vikneswaran ^a   Buttar, Navtej S ^a   Dunagan, Kelly T ^a   Prasad, Ganapathy A ^a  

^a MAYO CLINIC   (United States)

Author keywords

CT imaging; Esophageal carcinoma; Obesity; Risk factor

Indexed keywords

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; BODY FAT DISTRIBUTION; BODY MASS; CLINICAL ARTICLE; CONTINUING EDUCATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ESOPHAGITIS; ESOPHAGUS BIOPSY; ESOPHAGUS DYSPLASIA; FEMALE; GASTROESOPHAGEAL REFLUX; HUMAN; INTRAABDOMINAL FAT; LIPID STORAGE; LOWER ESOPHAGUS SPHINCTER; MALE; MEDICAL EDUCATION; RISK ASSESSMENT; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

ADIPOSE TISSUE; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; BIOPSY; BODY FAT DISTRIBUTION; CASE-CONTROL STUDIES; ESOPHAGITIS; FABACEAE; FEMALE; HISTOCYTOCHEMISTRY; HUMANS; MALE; METAPLASIA; MIDDLE AGED;

EID: 84862691710     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.03.007     Document Type: Article

References (35)

1. El-Serag H. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci 2008, 53:2307-2312.
2. El-Serag H. Role of obesity in GORD-related disorders. Gut 2008, 57:281-284.
3. Cook M.B., Greenwood D.C., Hardie L.J., et al. A systematic review and meta-analysis of the risk of increasing adiposity on Barrett's esophagus. Am J Gastroenterol 2008, 103:292-300.
4. Weinsier R.L., Hunter G.R., Gower B.A., et al. Body fat distribution in white and black women: different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr 2001, 74:631-636.
5. Corley D.A., Kubo A., Levin T.R., et al. Abdominal obesity and body mass index as risk factors for Barrett's esophagus. Gastroenterology 2007, 133:34-41. quiz, 311.
6. Edelstein Z.R., Farrow D.C., Bronner M.P., et al. Central adiposity and risk of Barrett's esophagus. Gastroenterology 2007, 133:403-411.
7. Pandolfino J.E. The relationship between obesity and GERD: "big or overblown". Am J Gastroenterol 2008, 103:1355-1357.
8. Pandolfino J.E., El-Serag H.B., Zhang Q., et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology 2006, 130:639-649.
9. El-Serag H.B., Ergun G.A., Pandolfino J., et al. Obesity increases oesophageal acid exposure. Gut 2007, 56:749-755.
10. El-Serag H.B., Tran T., Richardson P., et al. Anthropometric correlates of intragastric pressure. Scand J Gastroenterol 2006, 41:887-891.
11. Dandona P., Weinstock R., Thusu K., et al. Tumor necrosis factor-alpha in sera of obese patients: fall with weight loss. J Clin Endocrinol Metab 1998, 83:2907-2910.
12. Kern P.A., Ranganathan S., Li C., et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab 2001, 280:E745-E751.
13. Kern P.A., Saghizadeh M., Ong J.M., et al. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 1995, 95:2111-2119.
14. Schenk S., Saberi M., Olefsky J.M. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest 2008, 118:2992-3002.
15. Vozarova B., Weyer C., Hanson K., et al. Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion. Obes Res 2001, 9:414-417.
16. Larsson S.C., Wolk A. Obesity and colon and rectal cancer risk: a meta-analysis of prospective studies. Am J Clin Nutr 2007, 86:556-565.
17. Aune D., Greenwood D.C., Chan D.S., et al. Body mass index, abdominal fatness and pancreatic cancer risk: a systematic review and non-linear dose-response meta-analysis of prospective studies. Ann Oncol 2012, 23:843-852.
18. El-Serag H.B., Kvapil P., Hacken-Bitar J., et al. Abdominal obesity and the risk of Barrett's esophagus. Am J Gastroenterol 2005, 100:2151-2156.
19. Tilg H., Moschen A.R. Visceral adipose tissue attacks beyond the liver: esophagogastric junction as a new target. Gastroenterology 2010, 139:1823-1826.
20. Sharma P., Dent J., Armstrong D., et al. The development and validation of an endoscopic grading system for Barrett's esophagus: the Prague C & M criteria. Gastroenterology 2006, 131:1392-1399.
21. Buttar N.S., Wang K.K., Leontovich O., et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002, 122:1101-1112.
22. Rubenstein J.H., Dahlkemper A., Kao J.Y., et al. A pilot study of the association of low plasma adiponectin and Barrett's esophagus. Am J Gastroenterol 2008, 103:1358-1364.
23. Rubenstein J.H., Kao J.Y., Madanick R.D., et al. Association of adiponectin multimers with Barrett's oesophagus. Gut 2009, 58:1583-1589.
24. Kendall B.J., Macdonald G.A., Hayward N.K., et al. Leptin and the risk of Barrett's oesophagus. Gut 2008, 57:448-454.
25. Francois F., Roper J., Goodman A.J., et al. The association of gastric leptin with oesophageal inflammation and metaplasia. Gut 2008, 57:16-24.
26. Chung S.J., Kim D., Park M.J., et al. Metabolic syndrome and visceral obesity as risk factors for reflux oesophagitis: a cross-sectional case-control study of 7078 Koreans undergoing health check-ups. Gut 2008, 57:1360-1365.
27. Nam S.Y., Choi I.J., Ryu K.H., et al. Abdominal visceral adipose tissue volume is associated with increased risk of erosive esophagitis in men and women. Gastroenterology 2010, 139. 1902-1911.e2.
28. Souza R.F. The role of acid and bile reflux in oesophagitis and Barrett's metaplasia. Biochem Soc Trans 2010, 38:348-352.
29. Souza R.F., Huo X., Mittal V., et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009, 137:1776-1784.
30. Coussens L.M., Werb Z. Inflammation and cancer. Nature 2002, 420:860-867.
31. Beddy P., Howard J., McMahon C., et al. Association of visceral adiposity with oesophageal and junctional adenocarcinomas. Br J Surg 2010, 97:1028-1034.
32. McElholm A.R., McKnight A.J., Patterson C.C., et al. A population-based study of IGF axis polymorphisms and the esophageal inflammation, metaplasia, adenocarcinoma sequence. Gastroenterology 2010, 139. 204-212.e3.
33. Greer K.B., Thompson C.L., Brenner L., et al. Association of insulin and insulin-like growth factors with Barrett's oesophagus. Gut 2012, 61:665-672.
34. Vaughan T.L., Kristal A.R., Blount P.L., et al. Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 2002, 11:745-752.
35. Irlbeck T., Massaro J.M., Bamberg F., et al. Association between single-slice measurements of visceral and abdominal subcutaneous adipose tissue with volumetric measurements: the Framingham heart study. Int J Obes (Lond) 2010, 34:781-787.